GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C&R Research Inc (XKRX:359090) » Definitions » Asset Impairment Charge

C&R Research (XKRX:359090) Asset Impairment Charge : ₩0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is C&R Research Asset Impairment Charge?

C&R Research's Asset Impairment Charge for the three months ended in Mar. 2024 was ₩0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 was ₩0 Mil.

C&R Research Asset Impairment Charge Historical Data

The historical data trend for C&R Research's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C&R Research Asset Impairment Charge Chart

C&R Research Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
- - - -

C&R Research Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

C&R Research Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

C&R Research Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of C&R Research's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

C&R Research (XKRX:359090) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C&R Research Inc (XKRX:359090) » Definitions » Asset Impairment Charge
Comparable Companies
XKRX:347700 XKRX:263700 XKRX:032850 XKRX:390110 XKRX:099750 XKRX:071200 XKRX:226330 XKRX:032620 XKRX:315640 VEEV GEHC TSE:2413 HQY ASX:PME RCM TXG DOCS PGNY EVH TDOC
Traded in Other Exchanges
N/A
Address
412 Yeoksam-ro, C&R Building, Gangnam-gu, Seoul, KOR
Website
http://www.cnrres.com
C&R Research Inc provides a quotation on clinical trial service.

C&R Research (XKRX:359090) Headlines

No Headlines